Cargando…

Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation

We aimed to develop a berberine formulation to enhance the intestinal absorption and plasma concentrations of berberine through the inhibition of P-glycoprotein (P-gp)-mediated efflux and the intestinal metabolism of berberine in rats. We used pluronic P85 (P85) and tween 80, which have the potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Mihwa, Lim, Dong Yu, Lee, Chul Haeng, Jeon, Ji-Hyeon, Choi, Min-Koo, Song, Im-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558015/
https://www.ncbi.nlm.nih.gov/pubmed/32957491
http://dx.doi.org/10.3390/pharmaceutics12090882
_version_ 1783594545137582080
author Kwon, Mihwa
Lim, Dong Yu
Lee, Chul Haeng
Jeon, Ji-Hyeon
Choi, Min-Koo
Song, Im-Sook
author_facet Kwon, Mihwa
Lim, Dong Yu
Lee, Chul Haeng
Jeon, Ji-Hyeon
Choi, Min-Koo
Song, Im-Sook
author_sort Kwon, Mihwa
collection PubMed
description We aimed to develop a berberine formulation to enhance the intestinal absorption and plasma concentrations of berberine through the inhibition of P-glycoprotein (P-gp)-mediated efflux and the intestinal metabolism of berberine in rats. We used pluronic P85 (P85) and tween 80, which have the potential to inhibit P-gp and cytochrome P450s (i.e., CYP1A2, 2C9, 2C19, 2D6, and 3A4). A berberine-loaded mixed micelle formulation with ratios of berberine: P85: tween 80 of 1:5:0.5 (w/w/w) was developed. This berberine mixed micelle formulation had a mean size of 12 nm and increased the cellular accumulation of digoxin via P-gp inhibition. It also inhibited berberine metabolism in rat intestinal microsomes, without significant cytotoxicity, up to a berberine concentration of 100 μM. Next, we compared the pharmacokinetics of berberine and its major metabolites in rat plasma following the oral administration of the berberine formulation (50 mg/kg) in rats with the oral administration of berberine alone (50 mg/kg). The plasma exposure of berberine was significantly greater in rats administered the berberine formulation compared to rats administered only berberine, which could be attributed to the increased berberine absorption by inhibiting the P-gp-mediated berberine efflux and intestinal berberine metabolism by berberine formulation. In conclusion, we successfully prepared berberine mixed micelle formulation using P85 and tween 80 that has inhibitory potential for P-gp and CYPs (CYP2C19, 2D6, and 3A4) and increased the berberine plasma exposure. Therefore, a mixed micelle formulation strategy with P85 and tween 80 for drugs with high intestinal first-pass effects could be applied to increase the oral absorption and plasma concentrations of the drugs.
format Online
Article
Text
id pubmed-7558015
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75580152020-10-22 Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation Kwon, Mihwa Lim, Dong Yu Lee, Chul Haeng Jeon, Ji-Hyeon Choi, Min-Koo Song, Im-Sook Pharmaceutics Article We aimed to develop a berberine formulation to enhance the intestinal absorption and plasma concentrations of berberine through the inhibition of P-glycoprotein (P-gp)-mediated efflux and the intestinal metabolism of berberine in rats. We used pluronic P85 (P85) and tween 80, which have the potential to inhibit P-gp and cytochrome P450s (i.e., CYP1A2, 2C9, 2C19, 2D6, and 3A4). A berberine-loaded mixed micelle formulation with ratios of berberine: P85: tween 80 of 1:5:0.5 (w/w/w) was developed. This berberine mixed micelle formulation had a mean size of 12 nm and increased the cellular accumulation of digoxin via P-gp inhibition. It also inhibited berberine metabolism in rat intestinal microsomes, without significant cytotoxicity, up to a berberine concentration of 100 μM. Next, we compared the pharmacokinetics of berberine and its major metabolites in rat plasma following the oral administration of the berberine formulation (50 mg/kg) in rats with the oral administration of berberine alone (50 mg/kg). The plasma exposure of berberine was significantly greater in rats administered the berberine formulation compared to rats administered only berberine, which could be attributed to the increased berberine absorption by inhibiting the P-gp-mediated berberine efflux and intestinal berberine metabolism by berberine formulation. In conclusion, we successfully prepared berberine mixed micelle formulation using P85 and tween 80 that has inhibitory potential for P-gp and CYPs (CYP2C19, 2D6, and 3A4) and increased the berberine plasma exposure. Therefore, a mixed micelle formulation strategy with P85 and tween 80 for drugs with high intestinal first-pass effects could be applied to increase the oral absorption and plasma concentrations of the drugs. MDPI 2020-09-17 /pmc/articles/PMC7558015/ /pubmed/32957491 http://dx.doi.org/10.3390/pharmaceutics12090882 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kwon, Mihwa
Lim, Dong Yu
Lee, Chul Haeng
Jeon, Ji-Hyeon
Choi, Min-Koo
Song, Im-Sook
Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
title Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
title_full Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
title_fullStr Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
title_full_unstemmed Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
title_short Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
title_sort enhanced intestinal absorption and pharmacokinetic modulation of berberine and its metabolites through the inhibition of p-glycoprotein and intestinal metabolism in rats using a berberine mixed micelle formulation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558015/
https://www.ncbi.nlm.nih.gov/pubmed/32957491
http://dx.doi.org/10.3390/pharmaceutics12090882
work_keys_str_mv AT kwonmihwa enhancedintestinalabsorptionandpharmacokineticmodulationofberberineanditsmetabolitesthroughtheinhibitionofpglycoproteinandintestinalmetabolisminratsusingaberberinemixedmicelleformulation
AT limdongyu enhancedintestinalabsorptionandpharmacokineticmodulationofberberineanditsmetabolitesthroughtheinhibitionofpglycoproteinandintestinalmetabolisminratsusingaberberinemixedmicelleformulation
AT leechulhaeng enhancedintestinalabsorptionandpharmacokineticmodulationofberberineanditsmetabolitesthroughtheinhibitionofpglycoproteinandintestinalmetabolisminratsusingaberberinemixedmicelleformulation
AT jeonjihyeon enhancedintestinalabsorptionandpharmacokineticmodulationofberberineanditsmetabolitesthroughtheinhibitionofpglycoproteinandintestinalmetabolisminratsusingaberberinemixedmicelleformulation
AT choiminkoo enhancedintestinalabsorptionandpharmacokineticmodulationofberberineanditsmetabolitesthroughtheinhibitionofpglycoproteinandintestinalmetabolisminratsusingaberberinemixedmicelleformulation
AT songimsook enhancedintestinalabsorptionandpharmacokineticmodulationofberberineanditsmetabolitesthroughtheinhibitionofpglycoproteinandintestinalmetabolisminratsusingaberberinemixedmicelleformulation